Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors
Clinical trial NCT03954704 · TERMINATED
Trial details
- NCT number
- NCT03954704
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2020-10-27
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.